Today in FirstWord: Johnson & Johnson, canagliflozin, Cancer trial bias, Sleeping drug dose, Bayer, Skyla

Today in FirstWord: Johnson &amp; Johnson, canagliflozin, Cancer trial bias, Sleeping drug dose, Bayer, Skyla

FirstWord Pharmaceutical News for Friday, January 11, 2013

Published daily, FirstWord is a personalisable business intelligence resource for the busy pharmaceutical professional.  For more information on this time-saving tool, please visit www.firstwordpharma.com.

Business

Medicine

Business News

Published daily, FirstWord is a personalisable business intelligence resource for the busy pharmaceutical professional. For more information on this time-saving tool, please visit www.firstwordpharma.com.

Share FirstWord Pharmaceutical News for Friday, January 11, 2013

Sign up to save your podcasts

FirstWord Pharmaceutical News for Friday, January 11, 2013

FirstWord Pharmaceutical News for Friday, January 11, 2013